The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2026

Filed:

Jan. 17, 2024
Applicants:

Istituto Europeo Di Oncologia S.r.l., Milan, IT;

Università Degli Studi Di Milano, Milan, IT;

Inventors:

Saverio Minucci, Milan, IT;

Pier Giuseppe Pelicci, Milan, IT;

Seyed Amir Hosseini, Milan, IT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); A61K 31/135 (2006.01); A61K 31/165 (2006.01); A61K 31/167 (2006.01); A61K 31/18 (2006.01); A61K 31/325 (2006.01); A61K 31/343 (2006.01); A61K 31/366 (2006.01); A61K 31/4025 (2006.01); A61K 31/4045 (2006.01); A61K 31/407 (2006.01); A61K 31/4155 (2006.01); A61K 31/4184 (2006.01); A61K 31/437 (2006.01); A61K 31/44 (2006.01); A61K 31/4406 (2006.01); A61K 31/4439 (2006.01); A61K 31/445 (2006.01); A61K 31/47 (2006.01); A61K 31/473 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/5375 (2006.01); A61K 31/549 (2006.01); A61K 38/15 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/135 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/325 (2013.01); A61K 31/343 (2013.01); A61K 31/366 (2013.01); A61K 31/4025 (2013.01); A61K 31/4045 (2013.01); A61K 31/407 (2013.01); A61K 31/4155 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/4406 (2013.01); A61K 31/4439 (2013.01); A61K 31/445 (2013.01); A61K 31/47 (2013.01); A61K 31/473 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5375 (2013.01); A61K 38/15 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01);
Abstract

Provided herein are compositions and methods of treating cancer with combinations of cell cycle inhibitors and LSD1 inhibitors. In some aspects, the cell cycle inhibitor is a CDK4/6 inhibitor, e.g., palbociclib. In some aspects, the LSD1 inhibitor is MC2580 or DDP38003. The compositions and methods of the disclosure may be used to treat cancers including, but not limited to, leukemia, lung cancer, melanoma, or breast cancer. The cancers may be, for example, LSD1-inhibitor-resistant and/or comprise cells having a reduced level of p21 expression or a loss of p21 function.


Find Patent Forward Citations

Loading…